dihexa potency compared to bdnf Plasma Brain-Derived Neurotrophic Factor (BDNF)

Shared equipment logs help explain variance when multiple operators run the same protocol

Everyone is so friendly and treat you like you are part of their family

After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )

Improved sleep creates a positive feedback loop

Most people get enough vitamin B12 by eating a variety of foods

Here are key insights from the Huberman Lab podcast: Overview of BPC-157 Nature and Mechanism : BPC-157 is a synthetic peptide mimicking a naturally occurring peptide in the gut involved in tissue repair